InterCure Ltd (INCR) is not a strong buy at this time for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The technical indicators show a bearish trend, there are no significant positive catalysts, and the options data suggests minimal trading interest. Additionally, there is no recent news, financial performance data, or analyst ratings to support a buy decision.

Technical Analysis

The stock is in a bearish trend as indicated by the moving averages (SMA_200 > SMA_20 > SMA_5). The MACD histogram is negative and expanding, signaling downward momentum. RSI is at 25.842, which is in the neutral zone but leaning toward oversold territory. Key support and resistance levels are S1: 0.786 and R1: 0.918, with the current price below the pivot level (0.852), further confirming bearish sentiment.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Technical Summary

Sell

Buy

Positive Catalysts

NULL identified. No recent news, insider activity, or hedge fund trends to suggest a positive catalyst. No recent congress trading data available.

Neutral/Negative Catalysts

Bearish technical indicators, lack of trading interest in options data, no significant insider or hedge fund activity, and no recent news or financial performance data to support a positive outlook.

Financial Performance

No financial performance data available for the latest quarter.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst ratings or price target changes available.

Analyst Rating

Wall Street analysts forecast INCR stock price to rise

Buy

Hold

Sell

Current: 0.850

Low

Averages

High